https://myricxbio.com/myricx-pharma-launches-with-4-5m-financing-to-progress-its-novel-nmt-inhibitors-in-cancer/2023-10-13T16:14:13+01:00https://myricxbio.com/myricx-pharma-announces-board-and-executive-appointments/2021-04-20T08:41:13+01:00https://myricxbio.com/ed-tate-appointed-to-the-gsk-chair-in-chemical-biology/2023-03-09T10:01:07+00:00https://myricxbio.com/myricx-pharma-presents-positive-pre-clinical-poc-data-at-aacr-for-its-n-myristoyltransferase-inhibitor-nmti-adc-programme-alongside-new-biology-on-novel-moa-for-nmti/2023-04-18T08:11:59+01:00https://myricxbio.com/myricx-expands-its-adc-expertise-with-the-appointment-of-francesca-zammarchi-as-cso/2023-10-13T16:13:52+01:00https://myricxbio.com/myricx-enters-into-antibody-license-agreement-with-biocytogen/2023-10-13T16:14:01+01:00https://myricxbio.com/myricx-expands-its-leadership-team-with-the-appointment-of-dr-robert-mcleod-as-vp-clinical-development/2023-10-13T16:13:56+01:00https://myricxbio.com/myricx-bio-to-present-preclinical-data-validating-nmti-as-a-novel-adc-payload-class/2023-11-15T08:04:06+00:00https://myricxbio.com/myricx-bio-wins-best-poster-at-world-adc/2023-11-15T08:03:41+00:00https://myricxbio.com/myricx-bio-appoints-dr-chris-martin-biotech-entrepreneur-and-adc-pioneer-as-chairman-of-its-board-of-directors/2023-11-15T08:02:21+00:00https://myricxbio.com/myricx-bio-enters-into-an-exclusive-antibody-license-agreement-with-wuxi-biologics/2025-04-07T15:11:33+01:00https://myricxbio.com/enhanced-potential-of-myricxs-nmt-inhibitor-payloads-with-dual-senolytic-and-cytotoxic-modes-of-action-as-adc-cancer-therapies/2025-04-07T15:11:58+01:00https://myricxbio.com/myricx-bio-announces-90m-114m-series-a-financing-to-advance-its-novel-nmti-adc-therapeutics-into-clinical-development/2025-04-07T15:11:06+01:00https://myricxbio.com/myricx-bio-announces-board-changes/2025-04-07T15:10:50+01:00https://myricxbio.com/kadans-science-partner-welcomes-myricx-bio-to-london-innovation-centre/2024-09-12T14:01:20+01:00https://myricxbio.com/myricx-bio-announces-expansion-of-its-leadership-team-to-advance-nmti-adcs-into-clinical-development/2025-04-08T08:10:29+01:00https://myricxbio.com/asco-2025/2025-05-22T13:10:54+01:00https://myricxbio.com/esmo-congress-2025/2025-08-04T15:17:14+01:00https://myricxbio.com/16th-world-adc-san-diego-2025/2025-08-04T15:18:06+01:00https://myricxbio.com/18th-ebf-open-symposium-2025/2025-05-23T09:23:10+01:00https://myricxbio.com/ebcg-pharma-ppm-toolbox-2025/2025-05-23T09:24:13+01:00https://myricxbio.com/15th-annual-world-adc-london-2025/2025-05-23T09:25:13+01:00https://myricxbio.com/15th-world-adc-2025/2025-05-23T09:26:26+01:00https://myricxbio.com/esmo-2024/2025-05-23T09:37:21+01:00https://myricxbio.com/asco-annual-meeting-2024/2025-05-23T09:28:58+01:00https://myricxbio.com/adc-payload-summit-2024/2025-05-23T09:30:09+01:00https://myricxbio.com/24th-bioequity-europe-conference-2024/2025-05-23T09:32:13+01:00https://myricxbio.com/aacr-annual-meeting-2024/2025-05-23T09:33:31+01:00https://myricxbio.com/14th-world-adc-london-2024/2025-05-23T09:34:33+01:00https://myricxbio.com/17th-annual-european-life-sciences-ceo-forum-2024/2025-05-23T09:35:38+01:00https://myricxbio.com/myricx-bio-awarded-cancer-research-horizons-start-up-achievement-recognition-award-for-2025/2025-07-10T20:19:17+01:00https://myricxbio.com/adc-novel-conjugates-2025/2025-08-04T15:18:26+01:00https://myricxbio.com/myricx-bio-appoints-penny-fatato-as-global-head-of-clinical-operations-as-it-advances-its-nmti-adcs-toward-clinical-development/2025-08-20T07:52:59+01:00https://myricxbio.com/myricx-bio-appoints-jonathon-marks-bluth-as-vp-business-development/2025-09-08T14:06:51+01:00https://myricxbio.com/myricx-bio-further-strengthens-its-clinical-team-and-us-presence-with-the-appointment-of-david-ellis-as-vp-regulatory-affairs/2025-09-17T10:22:06+01:00https://myricxbio.com/adc-innovator-myricx-bio-appoints-boston-based-mohit-rawat-as-ceo-and-expands-team-in-us-and-uk/2025-09-22T08:05:39+01:00https://myricxbio.com/jpm-annual-healthcare-conference-2026/2026-01-02T11:12:02+00:00https://myricxbio.com/16th-world-adc-london/2026-01-02T11:09:04+00:00